Delivery Order SPE2DB24D2101-SPE2DB25FKGLN

Award Date 1/27/25
Potential Completion Date 2/18/25
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,352.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XEOMIN 200 unit vials, with a completion date of January 29, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a...
This federal contract award, with a ceiling value of $1,396.85, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, which is a delivery order, provides for the procurement of XEOMIN 100 UNIT VIALS. The contract has an ultimate completion date of February 6, 2025 and uses a firm-fixed-price pricing type. The award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $13,559.00, was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a delivery order for the provision of 4,566,773,316 units of the pharmaceutical product XEOMIN 200 UNIT VIALS. The contract has a firm fixed-price pricing type and an ultimate completion date of January 13, 2025. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $2,793.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,093,142 units of XEOMIN 100 UNIT VIALS, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of February 19, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $44,036.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XEOMIN 200 unit vials, a pharmaceutical product, with a completion date of December 10, 2024. The contract is structured as a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,559.10 firm fixed-price delivery order is for XEOMIN 50 UNIT VIALS, with a completion date of February 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award is for the delivery of XEOMIN 200 unit vials to the Defense Logistics Agency (DLA). The $6,290.88 firm fixed price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,145.00 firm-fixed-price delivery order is for the supply of XEOMIN 200 unit vials. The award is associated with a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This single-award IDC serves as the primary...
This federal contract award, valued at $46,934.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of XEOMIN 100 unit vials, a pharmaceutical product, to support federal healthcare programs. The award is a delivery order under a broader Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of XEOMIN 200 unit vials. The $16,270.80 firm fixed price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency within the Department of Defense. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA, which serves as a primary vehicle for providing a comprehensive...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB25FKGLN
    Delivery Order

This federal contract award, valued at $3,352.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XEOMIN 200 UNIT VIALS, a pharmaceutical product. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This particular delivery order has a firm fixed price and an ultimate completion date of February 18, 2025. The contract does not have any set-aside designation, indicating open competition.

Generated 4/28/25, 9:52 AM